PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Rifampicin combined preparations
Presentation Product Chemical substance Chapter Items dispensed
Rifinah 300mg/150mg tablets
0501090S0BBABAB
Rifinah Rifampicin combined preparations Infections 145
Rifampicin 300mg / Isoniazid 150mg tablets
0501090S0AAABAB
Rifampicin/isoniazid Rifampicin combined preparations Infections 114
Rifinah 150mg/100mg tablets
0501090S0BBAAAA
Rifinah Rifampicin combined preparations Infections 37
Rifater tablets
0501090S0BDAAAC
Rifater Rifampicin combined preparations Infections 22
Voractiv tablets
0501090S0BEAAA0
Voractiv Rifampicin combined preparations Infections 20
Rifampicin 150mg / Isoniazid 100mg tablets
0501090S0AAAAAA
Rifampicin/isoniazid Rifampicin combined preparations Infections 2
Generic Rifater tablets
0501090S0AAACAC
Rifampicin/isoniazid Rifampicin combined preparations Infections No data available
Rifampicin 300mg / Isoniazid 150mg capsules
0501090S0AAADAD
Rifampicin/isoniazid Rifampicin combined preparations Infections No data available
Rifater tablets (Imported)
0501090S0BDABAC
Rifater Rifampicin combined preparations Infections No data available
Rimactazid 150 tablets
0501090S0BCAAAA
Rimactazid Rifampicin combined preparations Infections No data available
Rimactazid 300 tablets
0501090S0BCABAB
Rimactazid Rifampicin combined preparations Infections No data available
Rimstar tablets
0501090S0BGAAA0
Rimstar Rifampicin combined preparations Infections No data available
Sinerdol Iso 300mg/150mg capsules
0501090S0BFAAAD
Sinerdol Rifampicin combined preparations Infections No data available
Voractiv (Imported)
0501090S0BEABA0
Voractiv Rifampicin combined preparations Infections No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.